// App-Quantinova.ai

M4116 2015 AHA : The Impact of Anti-angiogenic Isoform of Vascular Endothelial Growth Factor A in Patients with Pulmonary Hypertension

Researchers

Presenter

  • Kazuhiko Nakakzato

Principal Investigators

  • Koichi Sugimoto

  • Akiomi Yoshihisa

  • Takayoshi Yamaki

  • Hiroyuki Kunii

  • Hitoshi Suzuki

  • Shu-ichi Saitoh

  • Yasuchika Takeishi

Medical Centers

  • Fukusima Medical University, Fukushima, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary arterial hypertension

  • Congenital heart disease

  • Tricuspid regurgitation

  • Venous thrombosis

  • Hypertension

  • Chronic thromboembolic pulmonary hypertension

Biomarkers

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim